VIGILANCE GUIDELINES

Document NumberFile NameYearVersionDocument TypeDownload
ELECTRONIC SUBMISSION OF ADVERSE DRUG REACTION (ADR) REPORTS - E2B REPORTING20191Guideline
2.33Post-marketing reporting of adverse drug reactions to human medicines in South Africa20219Guideline
2.63GUIDELINE FOR ADVERSE DRUG REACTIONS (ADRs) REPORTING FOR HEALTHCARE PROFESSIONALS20211Guideline
6.28Valproate Annual Risk Acknowledgement Form20181Guideline
9.08Guideline for the handling of Dear Healthcare Professional
Letters relating to medicine safety
20205Guideline